(RDIV) Invesco S&P Ultra Dividend - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46138G6567
RDIV: Mid-Cap, Value, Dividend, Revenue, Stocks
The Invesco S&P Ultra Dividend Revenue ETF (RDIV) is an exchange-traded fund that tracks a specific index, investing at least 90% of its assets in the constituent securities. The underlying index is designed to capture the performance of S&P 900 Index companies with positive revenue, providing a unique blend of dividend income and revenue growth.
The funds investment strategy focuses on the S&P 900 Index, a broad representation of the US stock market, comprising large-cap, mid-cap, and small-cap stocks. By targeting companies with positive revenue, the index provider aims to create a portfolio that balances dividend yield with revenue stability. As a non-diversified fund, RDIV may exhibit higher volatility compared to its diversified counterparts.
Analyzing the funds recent price action, we observe a relatively stable trend, with the 20-day simple moving average (SMA) at $47.27, closely aligned with the last price of $47.32. The 50-day SMA at $46.50 indicates a potential support level, while the 200-day SMA at $48.18 suggests a longer-term resistance. The average true range (ATR) of 0.58, equivalent to 1.22%, implies moderate volatility.
Considering the funds assets under management (AUM) of $782.28 million, we can infer that RDIV has a reasonable level of liquidity, allowing investors to enter or exit positions without significantly impacting the market price. Furthermore, the ETFs mid-cap value category suggests that it may be an attractive option for investors seeking a balance between growth and income.
Based on the technical and fundamental data, our forecast suggests that RDIV may experience a short-term consolidation phase, potentially trading within the range of $46.50 to $48.18. However, if the S&P 900 Index continues to exhibit positive revenue growth, RDIV may benefit from the underlying trend, driving the price towards the 52-week high of $51.70. Conversely, a decline in revenue growth or a market correction may lead to a retest of the 52-week low of $42.44.
Additional Sources for RDIV ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
RDIV ETF Overview
Market Cap in USD | 775m |
Category | Mid-Cap Value |
TER | 0.39% |
IPO / Inception | 2013-09-30 |
RDIV ETF Ratings
Growth Rating | 68.0 |
Fundamental | - |
Dividend Rating | 59.8 |
Rel. Strength | -3.53 |
Analysts | - |
Fair Price Momentum | 48.48 USD |
Fair Price DCF | - |
RDIV Dividends
Dividend Yield 12m | 3.19% |
Yield on Cost 5y | 7.10% |
Annual Growth 5y | 3.34% |
Payout Consistency | 96.1% |
Payout Ratio | % |
RDIV Growth Ratios
Growth Correlation 3m | 27.8% |
Growth Correlation 12m | 9% |
Growth Correlation 5y | 86.6% |
CAGR 5y | 17.31% |
CAGR/Max DD 5y | 0.70 |
Sharpe Ratio 12m | 0.84 |
Alpha | -0.68 |
Beta | 0.631 |
Volatility | 17.42% |
Current Volume | 39.9k |
Average Volume 20d | 22.6k |
As of June 25, 2025, the stock is trading at USD 47.37 with a total of 39,921 shares traded.
Over the past week, the price has changed by +1.52%, over one month by +1.33%, over three months by -2.39% and over the past year by +9.20%.
Yes. Based on ValueRay´s Analyses, Invesco S&P Ultra Dividend (NYSE ARCA:RDIV) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.03 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RDIV is around 48.48 USD . This means that RDIV is currently overvalued and has a potential downside of 2.34%.
Invesco S&P Ultra Dividend has no consensus analysts rating.
According to our own proprietary Forecast Model, RDIV Invesco S&P Ultra Dividend will be worth about 54.7 in June 2026. The stock is currently trading at 47.37. This means that the stock has a potential upside of +15.41%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 54.7 | 15.4% |